Prostate biopsy guided by 18F-fluorocholine PET in men with persistently elevated PSA levels

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 35, Issue 8, 2008, Pages 1567-1569

  Kwee, Sandi A ^a,b,d   DeGrado, Tim ^c  

^a Hamamatsu/Queen's PET Imaging Center   (United States)

^b UNIVERSITY OF HAWAII   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d QUEEN S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROCHOLINE F 18; PROSTATE SPECIFIC ANTIGEN; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

CANCER DIAGNOSIS; CHOLINE UPTAKE; COMPUTER ASSISTED TOMOGRAPHY; ETHNICITY; HISTOPATHOLOGY; HUMAN; LETTER; NEEDLE BIOPSY; POSITRON EMISSION TOMOGRAPHY; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; RACE DIFFERENCE; RADIOACTIVITY; SENSITIVITY AND SPECIFICITY;

AGED; BIOPSY, NEEDLE; CHOLINE; FALSE NEGATIVE REACTIONS; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 48149090213     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-008-0781-6     Document Type: Letter

References (10)

1. 18F-Choline PET/CT in patients with elevated PSA-level and negative prostate needle biopsy for localisation of prostate cancer. Eur J Nucl Med Mol Imaging 2008;35(5):976-983; DOI 10.1007/s00259-007-0686-9.
2. SA Kwee MN Coel J Lim JP Ko 2005 Prostate cancer localization with 18fluorine fluorocholine positron emission tomography J Urol. 173 1 252 5
3. SA Kwee H Wei I Sesterhenn D Yun MN Coel 2006 Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET J Nucl Med. 47 2 262 9
4. AE Wefer H Hricak DB Vigneron 2000 Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology J Urol. 164 2 400 4
5. JB Rietbergen AE Kruger RF Hoedemaeker CH Bangma WJ Kirkels FH Schroder 1998 Repeat screening for prostate cancer after 1-year followup in 984 biopsied men: clinical and pathological features of detected cancer J Urol. 160 6 Pt 1 2121 5
6. TR DeGrado RE Coleman S Wang 2001 Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer Cancer Res. 61 1 110 7
7. DT Price RE Coleman RP Liao CN Robertson TJ Polascik TR DeGrado 2002 Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer J Urol. 168 1 273 80
8. 18F]fluorocholine in 9L glioma cells and 9L glioma-bearing fisher rats. Eur J Nucl Med Mol Imaging 2008; 35(6):1192-1203; DOI 10.1007/s00259-008-0736-y.
9. Y Aoki Y Arai H Maeda K Okubo K Shinohara 2001 Racial differences in cellular composition of benign prostatic hyperplasia Prostate. 49 4 243 50
10. G Hoke W Baker C Barnswell 2006 Racial differences in pathogenetic mechanisms, prevalence, and progression of benign prostatic hyperplasia Urology. 68 5 924 30